344 filings
Page 3 of 18
8-K
59zva8 06wg3m3cai
12 Jan 21
Other Events
12:00am
8-K
1r8jl1m7xwh 7s0j
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
lu1km95r09x5xpyg
14 Dec 20
Regulation FD Disclosure
9:12am
8-K
2qk2g 1bl
13 Nov 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
ihi408abruz7e1 s6omv
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
nb62gu03b
11 Jun 20
Other Events
9:00am
8-K/A
pdhs1
21 May 20
Material Modifications to Rights of Security Holders
12:00am
8-K
h95kd32iyz3ykrxxh
19 May 20
Material Modifications to Rights of Security Holders
8:30am
8-K
uwhzhsfxj
15 May 20
Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors
10:31am
8-K
ccsbxcw9
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
c0khg16
17 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
y40gu8p188 lhh
30 Mar 20
Departure of Directors or Certain Officers
4:16pm
8-K
zw61i458xlx2m rl
16 Mar 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm
8-K
5u8mzic 4u
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
8-K
jtjfv2
13 Feb 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm
8-K
lpb c8yhcm3m
11 Feb 20
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
6:08am
8-K
0k7r 2s5h3rh7qtg
3 Jan 20
Entry into a Material Definitive Agreement
4:33pm
8-K
wmu5yle3j
7 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
9h7sk1k
21 Oct 19
Entry into a Material Definitive Agreement
8:57am
8-K
v9f2nl0ql eb
27 Aug 19
Entry into a Material Definitive Agreement
4:31pm